{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,23]],"date-time":"2025-12-23T18:22:35Z","timestamp":1766514155867,"version":"build-2065373602"},"reference-count":17,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Emergency Medicine"],"published-print":{"date-parts":[[2020,5]]},"DOI":"10.1016\/j.ajem.2019.12.029","type":"journal-article","created":{"date-parts":[[2019,12,16]],"date-time":"2019-12-16T12:19:10Z","timestamp":1576498750000},"page":"1045.e1-1045.e2","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Development of severe serotonin syndrome from acute ingestion of vilazodone without co-ingestion"],"prefix":"10.1016","volume":"38","author":[{"given":"James","family":"Clevenger","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"McCabe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.ajem.2019.12.029_bb0005","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1097\/00004714-200202000-00007","article-title":"Severity of depression and response to antidepressants and placebo: an analysis of the Food and Drug Administration database","volume":"22","author":"Khan","year":"2002","journal-title":"J Clin Psychopharmacol"},{"issue":"1","key":"10.1016\/j.ajem.2019.12.029_bb0010","first-page":"28","article-title":"A serotonin partial agonist and reuptake inhibitor for the treatment of major depressive disorder","volume":"37","author":"Cruz","year":"2012","journal-title":"Pharm Ther"},{"issue":"3","key":"10.1016\/j.ajem.2019.12.029_bb0015","doi-asserted-by":"crossref","first-page":"326","DOI":"10.4088\/JCP.08m04637","article-title":"Evidence for efficacy and tolerability of vilazodone in the treatment of major depressive disorder","volume":"70","author":"Rickels","year":"2009","journal-title":"J Clin Psychiatry"},{"issue":"4","key":"10.1016\/j.ajem.2019.12.029_bb0020","doi-asserted-by":"crossref","first-page":"441","DOI":"10.4088\/JCP.10m06596","article-title":"A randomized, double-blind, placebo-controlled, 8-week study of vilazodone, a serotonergic agent for the treatment of major depressive disorder","volume":"72","author":"Khan","year":"2011","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.ajem.2019.12.029_bb0025","doi-asserted-by":"crossref","first-page":"3899","DOI":"10.2147\/DDDT.S122085","article-title":"Efficacy and tolerability of vilazodone for major depressive disorder: evidence from phase III\/IV randomized controlled trials","volume":"10","author":"Shi","year":"2016","journal-title":"Drug Des Devel Ther"},{"key":"10.1016\/j.ajem.2019.12.029_bb0030","article-title":"An 8-week randomized, double-blind trial comparing efficacy, safety, and tolerability of 3 vilazodone dose-initiation strategies following switch from SSRIs and SNRIs in major depressive disorder","author":"Rele","year":"2015","journal-title":"Prim Care Companion CNS Disord"},{"key":"10.1016\/j.ajem.2019.12.029_bb0035","doi-asserted-by":"crossref","DOI":"10.7759\/cureus.4185","article-title":"A review of novel antidepressants: a guide for clinicians","author":"Faquih","year":"2019","journal-title":"Cureus"},{"year":"2011","series-title":"Highlights of prescribing information: VIIBRYD: FDA, reference ID: 3018048","key":"10.1016\/j.ajem.2019.12.029_bb0040"},{"issue":"3","key":"10.1016\/j.ajem.2019.12.029_bb0045","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.jemermed.2015.04.032","article-title":"Acute vilazodone toxicity in a pediatric patient","volume":"49","author":"Acker","year":"2015","journal-title":"J Emerg Med"},{"issue":"6","key":"10.1016\/j.ajem.2019.12.029_bb0050","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/j.annemergmed.2012.06.020","article-title":"Recurrent seizure activity in a child after acute vilazodone ingestion","volume":"60","author":"Carstairs","year":"2012","journal-title":"Ann Emerg Med"},{"issue":"3","key":"10.1016\/j.ajem.2019.12.029_bb0055","article-title":"Seizures after pediatric vilazodone ingestion","volume":"34","author":"Pizzo","year":"2018","journal-title":"Pediatr Emerg Care"},{"key":"10.1016\/j.ajem.2019.12.029_bb0060","first-page":"533","article-title":"Serotonin syndrome","volume":"13","author":"Volpi-Abadie","year":"2013","journal-title":"Ochsner J"},{"issue":"11","key":"10.1016\/j.ajem.2019.12.029_bb0065","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1056\/NEJMra041867","article-title":"The serotonin syndrome","volume":"352","author":"Boyer","year":"2005","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.ajem.2019.12.029_bb0070","first-page":"28","article-title":"A serotonin partial agonist and reuptake inhibitor for the treatment of major depressive disorder","volume":"37","author":"Cruz","year":"2012","journal-title":"Pharm Ther"},{"issue":"Suppl. 3","key":"10.1016\/j.ajem.2019.12.029_bb0075","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1046\/j.1528-1157.43.s.3.5.x","article-title":"Children versus adults: pharmacokinetic and adverse-effect differences","volume":"43","author":"Anderson","year":"2002","journal-title":"Epilepsia"},{"key":"10.1016\/j.ajem.2019.12.029_bb0080","doi-asserted-by":"crossref","unstructured":"Nelson LS, Erdman AR, Booze LL, Cobaugh DK, Chyka PA, Woolf AD, Scharman EJ, Wax PM, Manuguerra AS, Christianson G, Caravati EM, Troutman WG. Selective serotonin reuptake inhibitor poisoning: an evidence-based consensus guideline for out-of-hospital management. Clin Toxicol, 45(4), 315\u2013332.","DOI":"10.1080\/15563650701285289"},{"key":"10.1016\/j.ajem.2019.12.029_bb0085","doi-asserted-by":"crossref","unstructured":"Heise CM, Malashock H, Brooks DE. A review of vilazodone exposures with focus on serotonin syndrome effects. Clin Toxicol, 55(9):1004\u20131007.","DOI":"10.1080\/15563650.2017.1332369"}],"container-title":["The American Journal of Emergency Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735675719308368?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735675719308368?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T15:47:08Z","timestamp":1760024828000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0735675719308368"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5]]},"references-count":17,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020,5]]}},"alternative-id":["S0735675719308368"],"URL":"https:\/\/doi.org\/10.1016\/j.ajem.2019.12.029","relation":{},"ISSN":["0735-6757"],"issn-type":[{"type":"print","value":"0735-6757"}],"subject":[],"published":{"date-parts":[[2020,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development of severe serotonin syndrome from acute ingestion of vilazodone without co-ingestion","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Emergency Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajem.2019.12.029","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}